Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
6.77
+0.07 (1.04%)
Feb 27, 2026, 3:00 PM CST

SHA:600351 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,6854,3855,2154,5286,9923,835
Market Cap Growth
8.26%-15.93%15.19%-35.24%82.33%-14.58%
Enterprise Value
4,0933,9524,9114,5207,1954,184
Last Close Price
6.775.636.235.278.044.37
PE Ratio
21.4418.0726.1343.2637.3735.71
Forward PE
-15.8915.8915.8915.8915.89
PS Ratio
2.061.631.791.672.531.47
PB Ratio
1.701.521.741.512.361.36
P/TBV Ratio
1.781.611.871.622.591.51
P/FCF Ratio
9.3510.0313.1111.3720.4212.06
P/OCF Ratio
8.589.3010.489.8315.9810.07
PEG Ratio
-2.552.552.552.552.55
EV/Sales Ratio
1.801.471.691.662.601.61
EV/EBITDA Ratio
9.699.5710.9813.3719.7714.56
EV/EBIT Ratio
13.7914.2816.8525.3836.5935.63
EV/FCF Ratio
8.179.0412.3511.3521.0113.15
Debt / Equity Ratio
0.040.030.070.150.180.23
Debt / EBITDA Ratio
0.240.230.461.291.472.26
Debt / FCF Ratio
0.200.220.531.111.572.04
Net Debt / Equity Ratio
-0.20-0.17-0.14-0.070.020.11
Net Debt / EBITDA Ratio
-1.32-1.17-0.91-0.670.171.03
Net Debt / FCF Ratio
-1.10-1.10-1.03-0.570.180.94
Asset Turnover
0.650.730.730.660.680.63
Inventory Turnover
3.393.102.802.512.152.03
Quick Ratio
2.351.831.601.401.231.05
Current Ratio
3.142.682.231.881.791.57
Return on Equity (ROE)
6.75%7.61%6.00%3.50%6.36%3.93%
Return on Assets (ROA)
5.27%4.68%4.56%2.71%3.04%1.76%
Return on Invested Capital (ROIC)
9.80%8.49%8.93%5.11%5.84%3.20%
Return on Capital Employed (ROCE)
10.30%9.30%9.50%5.80%6.40%4.00%
Earnings Yield
4.76%5.54%3.83%2.31%2.68%2.80%
FCF Yield
10.69%9.97%7.63%8.80%4.90%8.29%
Dividend Yield
5.97%5.33%2.41%0.95%1.00%1.15%
Payout Ratio
94.55%46.79%25.69%77.98%32.29%46.10%
Buyback Yield / Dilution
3.67%5.25%0.89%-0.02%0.04%0.86%
Total Shareholder Return
9.65%10.58%3.30%0.93%1.03%2.01%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.